Syddansk Universitet (University of Southern Denmark)
- Address
- lock Available on a paid plan
Neoplasms and Gynaecologic Oncology
Research at Syddansk Universitet in Odense focuses on ovarian cancer, especially FIGO stage III disease, with trials designed to assess whether adding new treatment approaches can improve survival after surgery.
- Primary ovarian cancer treatment and outcomes
- Hyperthermic intraperitoneal chemotherapy as an added cancer therapy
- Effectiveness of cytoreductive surgery strategies
This work aims to strengthen treatment results for advanced gynecologic cancers and refine care for patients eligible for major surgical management.
Nervous System Diseases and Migraine Research
The site also studies migraine and migraine without aura, exploring how symptoms develop in both men and women and testing whether certain medicines can help understand or trigger headache patterns.
- Migraine symptom patterns
- Headache and migraine-like attacks
- Sex-related differences in migraine response
These trials are aimed at improving knowledge of migraine biology and supporting the search for better prevention and treatment approaches.
Bacterial Infections and Mycoses
Clinical research in infectious diseases includes work on Group B streptococcus prevention, with attention to vaccine-related immune responses in pregnant women and healthy participants.
- Group B streptococcus infection prevention
- Vaccine immune response persistence
- Protection for pregnancy and newborn health
The goal is to support better prevention of maternal and neonatal infection through improved understanding of lasting antibody responses.
Cardiovascular Diseases and Related Mechanisms
The trial portfolio at University of Southern Denmark also spans cardiovascular-related and neurovascular questions, using medicines to explore how body signaling pathways may influence headache development.
- cAMP signaling in migraine
- Medicine-induced headache responses
- Potential links between vascular and migraine symptoms
This research helps clarify underlying biological mechanisms and may guide future approaches for more targeted symptom control.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 111 other sites in Denmark
Therapeutic Area Benchmark — Denmark
Select a therapeutic area to compare against other sites in Denmark.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Denmark
Market Share
Country: Denmark
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Syddansk Universitet (University of Southern Denmark)
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Hyperthermic Intraperitoneal Chemotherapy with Cisplatin in Stage III Epithelial Ovarian Cancer: A Randomized Phase III Trial | Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting | Phase III | Not Recruiting | Jan 2020 | — |
IMP list
lock Showing 1 of 14 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Ibuprofen | 3 | Unknown | 2024-11-01 | 2025-11-21 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.